Using health-economic evidence to support policy-level decision-making in Singapore-sensitivity analysis that provides further confidence in fracture probability-based cost-effective intervention thresholds.

Chandran, M; Ganesan, G; Tan, K B; Reginster, J-Y; Hiligsmann, M

Chandran, M; Ganesan, G; Tan, K B; Reginster, J-Y; Hiligsmann, M.

Afiliación

Chandran M; Osteoporosis and Bone Metabolism Unit, Department of Endocrinology, Singapore General Hospital, Singapore, Singapore. Manju.chandran@singhealth.com.sg.
Ganesan G; Ministry of Health, Singapore, Singapore.
Tan KB; Ministry of Health, Singapore, Singapore.
Reginster JY; School of Public Health, National University of Singapore, Singapore, Singapore.
Hiligsmann M; Center for Investigation in Bone and Articular Cartilage, University of Liege, Liege, Belgium.

Osteoporos Int ; 32(4): 787-789, 2021 Apr.

Article en En | MEDLINE | ID: mdl-33566137

Asunto(s)

Fracturas Osteoporóticas; Análisis Costo-Beneficio; Humanos; Fracturas Osteoporóticas/prevención & control; Políticas; Probabilidad; Singapur

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fracturas Osteoporóticas Tipo de estudio: Diagnostic_studies / Health_economic_evaluation Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Osteoporos Int Asunto de la revista: METABOLISMO / ORTOPEDIA Año: 2021 Tipo del documento: Article País de afiliación: Singapur

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google